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ABSTRACT 
Objective: The present study is an attempt to investigate the antioxidant and anticancer potential of hydroalcoholic extract of Mimosa pudica Linn 
(Mimosaceae) and L-Mimosine on Daudi cell line.  
Methods: The analysis of the standard compound L-Mimosine was ascertained by High Performance Thin Layer Chromatography (HPTLC). Free 
radical scavenging activity of M. pudica extract and L-Mimosine was also compared using 2, 2-diphenyl–1-picrylhydrazylradical scavenging assay 
(DPPH). Cell viability and cytotoxicity on Daudi cells were evaluated by trypan blue and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) assays in a dose and time-dependent manner respectively.  
Results: HPTLC analysis showed the presence of amino acids, amines, lipids in the hydroalcoholic extract of M. pudica. Crude hydroalcoholic extract 
of M. pudica showed antioxidant activity (IC50=103.88 µg/ml) whereas L-Mimosine showed antioxidant activity (IC50=233.06 µM). The crude 
extract and compound inhibited the proliferation and growth of the Daudi cells through induced cell death. The IC50
Conclusion: The results indicated the presence of L-Mimosine in the hydroalcoholic extract of M. pudica. The hydroalcoholic extract and pure 
compound proved potent inhibitors of cell proliferation, thus manifesting significant antioxidant and anticancer activity. 
 value for anticancer activity 
was found to be 201.65 µg/ml and 86.61 µM at 72 h for M. pudica extract and L-Mimosine respectively. 
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INTRODUCTION 
Cancer has been one of the most dreaded diseases of the 20th century 
and is increasing rampantly with greater intensity in the 21st
Over the last few decades, there has been increased interest by 
pharmaceutical industries to discover new drugs from the 
ethnobotanicals to provide new and alternative drugs to synthetic 
drugs for the treatment of dreadful diseases. Only a few plants have 
been significantly explored regarding their medicinal uses.  
 
century. Cancer in adolescent and young adults is 2.7 times more 
common than cancer occurring during the first 15 y of life. In 
females aged between 15 to 29 y, malignancies of the genital tract 
are the most frequent type of cancer (18%), followed by lymphoma 
(17%) [1].  
Antitumor drug resistance and side effects of antitumor compounds 
are the most common hurdles in medicine [2]. Plants are rich 
sources of anticancer agents and their derivatives are very useful for 
the treatment or prevention of cancer. These plant compounds such 
as vinblastine have been demonstrated as therapeutic for Hodgkin’s 
lymphoma and vincristine for non-Hodgkin’s lymphoma while 
Camptotheca acuminate, topotecan and irinotecan have been used 
for lung and ovarian cancer [3]. Anticancer activity is the effect of 
natural and synthetic or biological and chemical agents to reverse, 
suppress or prevent carcinogenic progression. Several synthetic 
agents are used to cure the disease but they have their cytotoxicity 
and hence the research is now focused towards investigating plant 
derived chemotherapeutic agents. 
Mimosa pudica known as “Chue Mue” belongs to taxonomic group 
Magnoliopsida and family Mimosaceae, is a stout straggling prostrate 
shrubby plant, with compound leaves that get sensitive on touching, 
pinous stipules and globose pinkish flower heads; it grows as a weed 
in almost all parts of the country. Leaves and stems of the plant have 
been reported to contain an amino acid Mimosine. The leaves also 
contain mucilage and roots contain tannins [4]. M. pudica leaves are 
used for its antihyperglycaemic, antiulcer, antidiarrheal, 
anticonvulsant, cytotoxic and hepatoprotective properties. Moreover, 
Paranjpe (1989) has reported that in Ayurvedic and Unani medicine, 
M. pudica root is used to treat bilious fever, piles, jaundice, leprosy, 
dysentery, vaginal and uterine complaints, inflammations and burning 
sensation, fatigue, asthma, leucoderma and blood diseases [5]. 
L-Mimosine or leucenol [C8H10N2O4
The cell line used in this study was Daudi cells which were cultured 
from a line of lymphoblastoid cells derived from a human Burkitt 
(non-Hodgkin) lymphoma which is cancer of the lymphatic system. 
We have studied the effect of hydroalcoholic extract of M. pudica and 
L-Mimosine on Daudi cells in vitro. 
, β-N-(3-hydroxy-4-pyridone)-
amino propionic acid] is an amino acid present in plants of genus 
Mimosa and Leucaena [6]. This rare amino acid exhibits a wide 
range of effects, including inhibition of folate metabolism [7], 
inhibition of deoxyribonucleotide metabolism [8], induction of 
apoptosis [9, 10], inhibition of different cell line proliferation and in 
vivo inhibition of tumor growth [11, 12]. It has shown an inhibitory 
effect on different mammalian enzymes such as tyrosinase, 
dopamine β-hydroxylase and deoxyhypusine hydroxylase [13, 14]. 
The aim of the current study is therefore to identify natural 
compounds that can be used for prevention or treatment of cancer. 
MATERIALS AND METHODS 
Chemicals 
L-Mimosine was purchased from MP Biomedicals (France) whereas all 
other chemicals were purchased from Hi-Media Laboratories (India). 
Preparation of plant extracts 
The plant of M. pudica was collected from Gujarat University campus 
and authenticated by Dr. H. A. Solanki, Professor, Botany 
Department, Gujarat University, Ahmedabad. The whole plant viz., 
stems, leaves, roots and flower buds of M. pudica were collected, 
washed and shade dried under ambient temperature. After complete 
drying plants were powdered and defatted with petroleum ether 
(40-60 °C) and kept for 24 h at room temperature with constant 
shaking. 50 gm of the defatted powdered material was capsulated in 
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filter paper and kept in the thimble, 500 ml solvent (water: ethanol) 
(70:30) was added into the flask and continuous extraction was 
carried out in the Soxhlet apparatus for 72-74 h at 60 °C, (till the 
colour in the siphon became colourless). The crude solvent collected 
in the flask was dried at reduced pressure and kept at 4 °C until 
further use. 
DPPH radical scavenging activity 
The antioxidant activity of plant extract and L-Mimosine was 
measured in vitro using DPPH, a stable free radical. The reaction 
mixture contained 0.1 ml of 0.1 mM DPPH and 0.1 ml of M. pudica 
extract (31.25-250 µg/ml) or L-Mimosine (31.25-250 µM). The 
solution was mixed rapidly and allowed to stand for 30 min in the 
dark. The scavenging activity was measured by noting the decrease 
in absorbance at 520 nm as compared to DPPH control. The analysis 
was done in triplicate. The assay procedure was followed from those 
described by Blois (1958) and Yamasaki et., al (1994)[15,16]. 
Inhibition of free radical DPPH in percent (I %) (or) the DPPH free 
radical scavenging activity (%) was calculated from the absorption 
according to the following equation:  
I (%) (Or) DPPH Scavenged (%) 
=
Absorbance of control - Absorbance of sample
Absorbance of control 
× 100 
Dose response curve was plotted between % inhibition and 
concentrations. IC50 
HPTLC 
values were found out for plant extract as well 
as for compound. 
The extract was first run along with the standard compound on Thin 
Layer Chromatography (TLC) plate through Phenol-Ethanol-Water 
(3:1:1) and spots were developed by ninhydrin spraying reagent 
(3% in acetone) [17]. This was then followed by scanning, 
determination of retention factor (Rf) value and λ Max profile [18] 
by Camag-5 HPTLC system WinCATS evaluation software (version 
1.4.6.8121). 
Cancer cell culture 
For cancer cell culture, Daudi cell line was obtained from the 
National Centre for Cell Science (NCCS), Pune. Cells were cultured in 
RPMI 1640 media with 10% fetal bovine serum (FBS) and antibiotic-
antimycotic solution. Cell cultures were maintained in a CO2 
incubator at 5% CO2 
Cell viability assays by trypan blue dye exclusion technique 
and 37 °C. 
Any compound, which is cytotoxic to cells, inhibits the cell growth 
proliferation and kills the cells. Trypan blue is a supravital dye, used 
to estimate the number of cells present in the population [19]. It has 
the ability to penetrate dead cells and give it a blue colour. This 
method gives a score of dead and viable cells [20]. 
Cellular cytotoxicity induced by the M. pudica extract and L-
Mimosine was measured with trypan blue exclusion assay. Sterility 






 cells were 
seeded into 24-well plates and treated with or without (as control) 
crude hydroalcoholic extract of M. pudica (12.5-400 µg/ml) and L-
Mimosine (12.5-400 µM) for 24, 48 and 72 h. After the incubation 
period, the cultures were harvested and washed twice with 
Phosphate Buffered Saline (PBS). The cell pellet was then 
resuspended with 0.5 ml PBS. Then, 20 μL of cells were mixed with 
equal volume of 0.4% trypan blue and was counted using a 
Neubauer hemocytometer by clear field microscopy. Viable and non-
viable cells were counted. The percentage cytotoxicity was 
calculated using the equation shown below:  
In vitro cytotoxicity determination by MTT assay 
The ability of cells to survive a toxic insult is the basis of most 
cytotoxic assays. This assay is based on the assumption that dead 
cells or their products do not reduce tetrazolium. It is described by 
the modified method of Mosmann, (1983) and Wilson et al., (2000) 
[21, 22].  
The assay detects the reduction of MTT by mitochondrial 
dehydrogenase to blue formazan product, which reflects the normal 
function of mitochondria. 2×106 viable cells/ml were plated into the 
96-well cell culture plate. The crude extract was added with the 
concentrations (12.5-400 µg/ml) and compound with (12.5-400 µM) 
respectively for 24, 48 and 72 h and incubated at 37 °C. After 
incubation, the supernatants were removed and incubated with MTT 
(0.5 v/v) in RPMI 1640 without FBS for 4 h in a humidified 
atmosphere at 37 °C and 5% CO2
The absorbance (A) of the coloured solution was quantified at 540 nm 
wavelengths by an enzyme-linked immunoabsorbent assay reader 
(ELISA READER, MERCK MIOS mini). Each extract, compound and 
control was assayed in triplicate in three independent experiments. 
Percent growth inhibition of cells exposed to treatments was 
calculated as follows:  
% Inhibition 
= �100 − �
Corrected mean Absorbance of sample
Corrected mean Absorbance of control
�� × 100 
 incubator.  
Statistical analysis 
Each parameter was performed in triplicate and the results were 
expressed as mean±standard error. The data was statistically 
analyzed by Student’s ‘t’ test and the values of p<0.05 were 
considered statistically significant.  
RESULTS 
Antioxidant effect M. pudica and L-Mimosine  
The DPPH radical scavenging activity of extract and L-Mimosine is 
shown in the fig. 1. It was observed that DPPH free radical scavenging 
activity was concentration dependent in both the cases and reaches a 
maximum at a concentration of 250 µg/ml for plant extract and 250 
µM for the compound. Our result indicated that M. pudica extract 
exhibited high antioxidative activity compared to L-Mimosine. 
 
 
Fig. 1: DPPH scavenging activity of Mimosa pudica with IC50 value 
of 103.88 µg/ml andL-Mimosine with IC50
Values are mean±S.E. for three individual experiments. 
 value of 233.06 µM 
 
HPTLC  
The peak heights area of the respective L-Mimosine standard and 
the hydroalcoholic plant extract are shown in fig. 2 and 3. The 
hydroalcoholic plant extract showed ten prominent spots on the TLC 
plate with a retention factor of 0.09, 0.12, 0.21, 0.29, 0.45, 0.52, 0.62, 
0.67, 0.84 and 0.94 (fig.3). HPTLC determination showed the 
presence of amino acids, amines, lipids in the hydroalcoholic extract 
of M. pudica and it was confirmed from the chromatogram after 
derivatization with Ninhydrin spraying reagent (fig. 4).  
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Fig. 2: HPTLC chromatogram area and peaks of the L-
Mimosine using Win CATS evaluation software (version 
1.4.6.8121) 
 
Fig. 3: HPTLC chromatogram area and peaks of the Mimosa 




Fig. 4: Thin layer chromatogram of Mimosa pudica and L-
Mimosine using the solvent system Phenol: Ethanol: Water 
(3:1:1 v/v/v) under 254 nm (A) and visible light (B) 
 
Cell viability assay 
The cell viability assay conducted by trypan blue dye exclusion 
method showed that there was a highly significant (p<0.001) 
decrease in viability with an increase in time and concentration in 
both the extract as well as pure compound treated Daudi cells as 
compared to untreated controlled cells.(fig. 5 and 6). 
 
 
Fig. 5: Effect of Mimosa pudica extract on percentage viability on 




Fig. 6: Effect of L-Mimosine on percentage viability on daudi cells. 
Values are mean±SE for three individual experiments. Except for 
treatment with 12.5 µM and 25 µM, there is a highly significant 
(p<0.001) decrease of cell viability in all treated cells 
 
 
Fig. 7: Effect of Mimosa pudica extract on the percentage 
decrease of growth proliferation in Daudi cells. Values are 
mean±SE for three individual experiments. Highly significant 




Daudi cells were grown in 96 well plates for 24, 48 and 72 h with 
different concentration (12.5-400 µg/ml) of the crude plant extract 
and (12.5-400 µM) L-Mimosine compound. The formazan crystals 
were formed, following the reduction of MTT by metabolically active 
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(viable) cells. The percentage decrease of proliferation after 
treatment with the M. pudica and L-Mimosine is given in Fig.7 and 8 
respectively compared to control. The IC50 
 
value was calculated by 
plotting the graph in Microsoft Excel and was found to be 201.65 
µg/ml and 86.61 µM at 72 h for M. pudica extract and L-Mimosine 
respectively. There was a significant increase in the percentage of 
inhibition of growth proliferation with increased dose and time 
duration as compared to untreated control cells (p<0.001). 
 
Fig. 8: Effect of L-Mimosine extract on the percentage decrease of 
growth proliferation in Daudi cells. Values are mean±SE for three 
individual experiments. Highly significant (p<0.001) increase in 
growth inhibition was observed in all the treated samples 
 
DISCUSSION 
The greatest challenge for phytochemical and pharmacological 
studies involves the identification of the specific compounds that are 
responsible for the beneficial effects and their modes of action, 
thereby delineating their useful functions as therapeutic drugs. 
Mimosa pudica Linn is a well-known herbal medicine throughout the 
world. Many studies have reported the pharmacological efficacies 
and benefits of M. pudica. Jose et., al. (2014) have shown potential 
anticancer activity with isolated flavonoids of M. pudica against 
MCF-7, human breast cancer cell line. Cytotoxic activity of M. pudica 
was evaluated using brine shrimp lethality bioassay which had 
shown little cytotoxic effect and results suggest that the plant can be 
used as a promising source of anticancer compounds [24]. There is 
very little information available on its mechanism of action on 
cancer cells. On the other hand, Lalande and Hanauske-Abel (1990) 
have shown that Mimosine induces cell-arrest (reversibly) late in the 
G1 phase of the cell cycle.  
Moreover, Mimosine is known to be a tyrosine analog that contains a 
metal chelating domain and hence it is able to chelate transition 
metals, such as Fe3+
DPPH has been used to evaluate the free radical scavenging activity 
of the natural antioxidant. DPPH which is a radical itself with a 
yellow color, changes into a stable compound antioxidant and the 
extent of the reaction depends on the hydrogen donating ability of 
the antioxidant [34]. Both extract and compound showed potent free 
radical scavenging activity with IC
(Linn et al. 1996). The possible structure of the 
Fe (III)-Mimosine chelation complex has also been proposed by Tsai 
and Ling (1973). Furthermore, there is evidence that Mimosine 
inhibits various mammalian enzymes in vitro, such as tyrosinase, 
dopamine hydroxylase [13], deoxyhypusyl hydroxylase (DOHH) 
[28], and H1 kinase [29]. These results strongly suggest that 
Mimosine may inhibit the intense mitotic activity of cancer cells. In 
fact, in vitro studies have demonstrated that Mimosine represses 
uterine cancer cell growth [30] and blocks DNA replication in both 
breast cancer and Chinese hamster ovary cells [31]. It has been 
shown that Mimosine acts as an iron chelator [32] and the resulting 
iron deficiency could alter folate metabolism in mammals and 
interfere with tumor cell growth [33]. The DPPH assay is based on 
the reduction of stable radical DPPH to yellow coloured diphenyl 
picryl hydrazine. Thus, the ability of the tested products to quench 
this radical is a measure of its antioxidative ability. Many previous 
studies have reported strong to the moderate free radical activity of 
crude extracts of the plants belonging to Mimosaceae. Normal cells 
have been studied previously in the same experiment and no 
significant effect has been found on normal cells. 
50
In this study, hydroalcoholic extract of M. pudica and L-Mimosine 
were used to evaluate their possible anticancer activity. Both M. 
pudica hydroalcoholic extract and L-Mimosine treatment caused a 
significant loss of viability of cells as measured by this assay in a 
dose and time-dependent manner respectively. 
 value of 103.88 µg/ml and 
233.06 µM respectively. The ability of the extract of M. pudica and L-
Mimosine to scavenge DPPH radicals suggests that it can react with 
free radicals to convert them to more stable products and terminate 
radical chain reaction. 
The cytotoxic activity was monitored by the standard MTT assay. 
The ability of cells to survive a toxic insult is the basis of most 
repeated cytotoxic assays. This assay depends on both on the 
mitochondrial activity per cell and number of cells present. The 
cleavage of MTT to a blue formazon derivative by living cells is 
clearly a very effective principle on which the assay is based 
conforming the decrease in survival of the cultured cells. 
The loss of viability and anticancer effect of L-Mimosine on Daudi cell 
line is might be due to inhibition of cellular enzymes in vitro [30].  
CONCLUSION 
The present study reported L-Mimosine from Mimosa pudica. 
Present data indicate that L-Mimosine treatment exhibited less 
antioxidant activity. Treatment with both hydroalcoholic extracts of 
M. pudica/ L-Mimosine showed potent anticarcinogenic effects 
against Daudi Lymphoma cell line leading to anti proliferation and 
loss of cell viability. To conclude data suggested that L-Mimosine 
treatment exhibited much higher anticarcinogenic activity compared 
to the extract of M. pudica. 
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